Forget Weight Loss: Eli Lilly's Real Upside Is As An AI Compounder
We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-06-30T08:02:28.000Z","dateModified":"2026-06-30T08:04:07.000Z","description":"Eli Lilly is leveraging its exceptional cash flow to build an AI-native drug discovery and manufacturing platform. Currently working towards the CFA charter, having completed I&II.
- ▪We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools.
- ▪Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-06-30T08:02:28.000Z","dateModified":"2026-06-30T08:04:07.000Z","description":"Eli Lilly is leveraging its exceptional cash flow to build an AI-na
- ▪Currently working towards the CFA charter, having completed I&II.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Stock Ideas","item":"https://seekingalpha.com/stock-ideas"},{"@type":"ListItem","position":3,"name":"Long Ideas","item":"https://seekingalpha.com/stock-ideas/long-ideas"},{"@type":"ListItem","position":4,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4918719-forget-weight-loss-eli-lillys-stock-real-upside-is-as-an-ai-compounder"},"author":{"@type":"Person","name":"Cavenagh…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
